Kiniksa Pharmaceuticals International (KNSA) Other financing activities (2022 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Other financing activities of $5.47 million for Q2 2026, up 167.1% from $2.05 million a year earlier.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Other financing activities (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's Other financing activities came in at $11.06 million, up 92.3% year-over-year; for FY2025, it came in at $7.73 million, up 55.1% from FY2024.
- Other financing activities has increased for three consecutive years, with a three-year compound annual growth rate of 104.7% (FY2022 to FY2025).
- By year, Other financing activities came in at $4.98 million in FY2024 (+125.9%), $2.21 million in FY2023 (+144.8%) and $901,000 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Other financing activities in data going back to Q1 2022.
- Year over year, Other financing activities gained in seven of the last eight quarters, with growth averaging 74.2%.
- The high point for year-over-year Other financing activities in five years was Q3 2023 (growth of 431.3%); the low point was Q1 2023 (a decline of 26.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $316,000 (Q1 2026), $918,000 (Q4 2025) and $4.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.47 Mn |
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 918,000.00 |
| Sep 30, 2025 | 4.35 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 412,000.00 |
| Dec 31, 2024 | 578,000.00 |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 381,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 419,000.00 |
| Mar 31, 2023 | 420,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 569,000.00 |
API Access
Kiniksa Pharmaceuticals International Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();